Tobacco company BAT ready to test possible Covid-19 vaccine on humans
British American Tobacco says it has submitted a pre-investigative new drug application to the US Food and Drug Administration
15 May 2020 - 15:58
Bengaluru — British American Tobacco (BAT), the world's number two cigarette company, said on Friday that it was ready to test its potential Covid-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
The maker of Lucky Strike cigarette said once it gets approval from the US Food and Drug administration (FDA) for the vaccine, it would progress to phase 1 trials — testing on humans...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.